Tag: health products

Careington Launches Strategic Relationship With e123 to Expand Noninsurance Benefits Offerings Available Through Streamlined Enrollment Portal

Three Careington savings plans have been added to the expansive suite of products supported by e123's platform. FRISCO, Texas, July 9, 2025 /PRNewswire/ -- Careington International...

Inside information: Orion upgrades full-year outlook for 2025

ORION CORPORATION
STOCK EXCHANGE RELEASE – INSIDE INFORMATION
9 JULY 2025 at 13.00 EEST

Visium Pro Releases 2025 Transparency Update on Vision Wellness Ingredients and Non-Prescription Eye Health Trends

As Consumers Search for the Best Non-Prescription Eye Supplements in 2025, Visium Pro Highlights Clean Label Formulation, GMP Manufacturing, and Ingredient Transparency for Digital Eye Strain and Screen Fatigue Support

As Consumers Search for the Best Non-Prescription Eye Supplements in 2025, Visium Pro Highlights Clean Label Formulation, GMP Manufacturing, and Ingredient Transparency for Digital Eye Strain and Screen Fatigue Support

Novartis receives approval for first malaria medicine for newborn babies and young infants

Basel, July 8, 2025 – Novartis today announced Coartem^® (artemether-lumefantrine) Baby has been approved by Swissmedic as the first malaria medicine for newborns and young infants. The new treatment, also known as Riamet^® Baby in some countries, was developed in collaboration with Medicines for Malaria Venture (MMV) to treat the potentially deadly mosquito-borne disease.

Sun’s Out, Fun’s On Deck: 8 Ways to Use Tax-free Flexible Spending Account (FSA), Health Savings Account (HSA) Funds to Protect Your Health this...

From award-winning skincare products to first aid, hydration, sunscreen, and bug bite relief, FSAs and HSAs help families and individuals make the most of summer fun...

Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health

Human Clinical Trial of L-Ergothioneine (Dr.Ergo®) on Skin Health

Public Advisory – NRA-Amlodipine 5 mg tablets: One lot recalled as some bottles may contain the wrong drug

OTTAWA, ON, July 5, 2025 /CNW/ - Summary Product: NRA-Amlodipine 5 mg, DIN 02476460Issue: Health products - Product safetyWhat to do: Check your bottle of NRA-Amlodipine 5 mg...

Orion publishes Half-Year Financial Report for January–June 2025 and holds a webcast on 18 July 2025

ORION CORPORATION
PRESS RELEASE
4 JULY 2025 at 09.00 EEST

Brain Defender Enters 2025 Cognitive Wellness Spotlight as Demand for Transparent, Non-Stimulant Support Surges

As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.

As consumers turn to ingredient-based mental clarity tools, Brain Defender emphasizes formulation transparency and non-clinical support in the evolving cognitive wellness space.

Apotex receives Health Canada approval for Aflivu™, a biosimilar to Eylea®, available in pre-filled syringe and vial formats

TORONTO, July 2, 2025 /PRNewswire/ - Apotex Inc. ("Apotex" or the "Company"), the Canadian-based global health company, today announced that Health Canada has approved Aflivu™ (aflibercept),...

GlucoTru Pro Releases 2025 Health Integrity Update on Blood Pressure & Blood Sugar Balance Innovation

In this 2025 public health alignment update, GlucoTru Pro emphasizes the growing consumer awareness of natural metabolic support strategies, including non-synthetic approaches to managing blood pressure, blood sugar, and overall wellness. This release provides new insights into public commentary themes, recent transparency in ingredient sourcing, and the alignment of the GlucoTru Pro formula with broader non-pharmaceutical health discussions.

In this 2025 public health alignment update, GlucoTru Pro emphasizes the growing consumer awareness of natural metabolic support strategies, including non-synthetic approaches to managing blood pressure, blood sugar, and overall wellness. This release provides new insights into public commentary themes, recent transparency in ingredient sourcing, and the alignment of the GlucoTru Pro formula with broader non-pharmaceutical health discussions.

VITALITY ANNOUNCES FIRST QUARTER RESULTS

TSXV Trading Symbol: VPI VANCOUVER, BC, June 30, 2025 /CNW/ - Vitality Products Inc. (TSXV: VPI) (the "Company" or "Vitality"), a manufacturer, marketer and distributor...

Pet King Brands’ ZYMOX® Designated as a 2025 Vanguard Awards Winner in Eye and Ear Care

Pet Insight Magazine recognizes ZYMOX as a category trailblazer. AUSTIN, Texas, June 30, 2025 /PRNewswire/ -- Pet King Brands, a pioneering leader in veterinarian-recommended enzymatic...

Health Canada launches public consultation on proposed changes to increase oversight of precursor chemicals and drug equipment

OTTAWA, ON, June 27, 2025 /CNW/ - The Government of Canada is taking action to keep communities safe on both sides of the border....

IMAAVY® (nipocalimab-aahu) demonstrates durable hemoglobin response and rapid onset of effect in pivotal Phase 2/3 study in warm autoimmune hemolytic anemia (wAIHA), an autoantibody-driven...

MILESEEY Tools und magicplan geben strategische Partnerschaft bekannt und stellen gemeinsames Co-Branding S50R-Lasermessset vor

Finance firms face surging AI risks as conduct incidents average USD 14 million